Valuation Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:02 25/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 108.32 USD | -0.07% |
|
+3.51% | +35.15% |
| 08-19 | Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating | MT |
| 08-18 | Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma | MT |
Company Valuation: Haemonetics Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,068 | 3,992 | 4,335 | 3,175 | 2,511 | 4,928 | - | - |
| Change | - | 30.13% | 8.58% | -26.76% | -20.89% | 96.24% | - | - |
| Enterprise Value (EV) 1 | 3,582 | 4,473 | 4,335 | 4,093 | 3,490 | 5,590 | 5,255 | 4,897 |
| Change | - | 24.89% | -3.1% | -5.58% | -14.71% | 60.16% | -5.99% | -6.82% |
| P/E | 71.5x | 35.3x | 37.3x | 19.1x | 26.4x | 27.3x | 24x | 20.8x |
| PBR | 4.09x | 4.88x | - | 3.71x | 3.21x | 4.63x | 3.61x | 2.91x |
| PEG | - | 0x | 16.71x | 0.4x | -0.7x | 0.3x | 1.8x | 1.3x |
| Capitalization / Revenue | 3.09x | 3.42x | 3.31x | 2.33x | 1.88x | 3.48x | 3.31x | 3.12x |
| EV / Revenue | 3.61x | 3.83x | 3.31x | 3.01x | 2.62x | 3.95x | 3.53x | 3.1x |
| EV / EBITDA | 12.6x | 14.7x | 11.7x | 9.67x | 7.93x | 12.4x | 10.8x | 9.01x |
| EV / EBIT | 19.1x | 20.5x | 15.7x | 12.5x | 10.3x | 15.2x | 13.3x | 11.3x |
| EV / FCF | - | - | 37.5x | 33.7x | 13.4x | 17.6x | 15.7x | 13.7x |
| FCF Yield | - | - | 2.66% | 2.96% | 7.46% | 5.67% | 6.37% | 7.31% |
| Dividend per Share 2 | - | - | - | - | - | 1 | - | - |
| Rate of return | - | - | - | - | - | 0.92% | - | - |
| EPS 2 | 0.84 | 2.24 | 2.29 | 3.31 | 2.05 | 3.963 | 4.507 | 5.21 |
| Distribution rate | - | - | - | - | - | 25.2% | - | - |
| Net sales 1 | 993.2 | 1,169 | 1,309 | 1,361 | 1,334 | 1,415 | 1,489 | 1,580 |
| EBITDA 1 | 284.9 | 304.7 | 370.1 | 423.3 | 440.1 | 450.9 | 486.7 | 543.4 |
| EBIT 1 | 187.1 | 218.4 | 276.5 | 326.3 | 338.5 | 367.3 | 396.2 | 432.8 |
| Net income 1 | 43.38 | 115.4 | 117.6 | 167.7 | 97.31 | 177.4 | 207.2 | 239.6 |
| Net Debt 1 | 514.1 | 481.4 | - | 918 | 979.1 | 662 | 327.1 | -31.34 |
| Reference price 2 | 60.02 | 79.13 | 85.35 | 63.19 | 54.04 | 108.32 | 108.32 | 108.32 |
| Nbr of stocks (in thousands) | 51,112 | 50,448 | 50,786 | 50,237 | 46,471 | 45,497 | - | - |
| Announcement Date | 10/05/22 | 11/05/23 | 09/05/24 | 08/05/25 | 07/05/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.33x | 3.95x | 12.4x | 0.92% | 4.93B | |
| 33.31x | 4.47x | 17.18x | 2.21% | 201B | |
| 20.52x | 3.55x | 12.54x | 3.26% | 117B | |
| 17.96x | 0.21x | 13.09x | 0.73% | 62.6B | |
| 30.45x | 7.57x | 19.35x | 1.31% | 52.49B | |
| 36.57x | 3.5x | 12.01x | 2.07% | 51.69B | |
| 35.74x | 6.29x | 19.74x | -.--% | 33.65B | |
| 46.78x | 1.32x | 12.06x | 0.16% | 31.27B | |
| 40.64x | 7.12x | 25.55x | 0.26% | 24.52B | |
| 20.06x | 3.09x | 11.28x | 1.43% | 24.05B | |
| Average | 30.94x | 4.11x | 15.52x | 1.24% | 60.28B | |
| Weighted average by Cap. | 29.83x | 4.02x | 15.55x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HAE Stock
- Valuation Haemonetics Corporation
Select your edition
All financial news and data tailored to specific country editions
